Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QuaCell Biotechnology
Zhongshan, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
QuaCell Biotechnology is a commercial biologics-focused CRO/CMO that offers cell line development, culture media, and process development services and GMP-oriented manufacturing support for antibodies and recombinant proteins; it supplies CHO cell lines and chemically defined CHO media and feeds used in biopharmaceutical R&D and manufacturing, including products registered in US DMFs[3][5][9][11].
- Modalities
- BiologicProteinRecombinant proteinMonoclonal antibody
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on QuaCell Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QuaCell Biotechnology.